OTCMKTS:XSNX NovAccess Global Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding NovAccess Global Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.15 -0.03 (-15.01%) (As of 06/24/2022 02:15 PM ET) Add Compare Share Today's Range$0.15▼$0.2550-Day Range$0.10▼$0.4852-Week Range$0.10▼$0.96Volume7,501 shsAverage Volume4,652 shsMarket Capitalization$2.76 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort Interest View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive XSNX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NovAccess Global and its competitors with MarketBeat's FREE daily newsletter. Email Address XSNX Stock Forecast (MarketRank)Overall MarketRank™0.91 out of 5 starsAnalyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 - 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for NovAccess Global. Previous Next 4.5 Community Rank Outperform VotesNovAccess Global has received 94 “outperform” votes. (Add your “outperform” vote.)Underperform VotesNovAccess Global has received 43 “underperform” votes. (Add your “underperform” vote.)Community SentimentNovAccess Global has received 68.61% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about NovAccess Global and other stocks. Vote “Outperform” if you believe XSNX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe XSNX will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldNovAccess Global does not currently pay a dividend.Dividend GrowthNovAccess Global does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, NovAccess Global insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.44% of the stock of NovAccess Global is held by insiders. Previous Next 0.0 Earnings and Valuation Previous Next See Top Rated MarketRank™ Stocks Here About NovAccess Global (OTCMKTS:XSNX)NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio.Read More XSNX Stock News HeadlinesJune 16, 2022 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global CEO Dwain Irvin Featured on MoneyTVJune 14, 2022 | finance.yahoo.comNovAccess Global CEO Dwain Irvin Featured on MoneyTVJune 10, 2022 | finance.yahoo.comThis Week on MoneyTV with Donald Baillargeon, 6/10June 1, 2022 | americanbankingnews.comNovAccess Global (OTCMKTS:XSNX) Trading 47.2% Higher May 19, 2022 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global to Participate in LD Micro Invitational XII ConferenceMay 19, 2022 | finance.yahoo.comNovAccess Global to Participate in LD Micro Invitational XII ConferenceMarch 17, 2022 | finance.yahoo.comNovAccess Global Stock Redemption and Expanded Board of Directors Reinforces Shareholder Value and Positions the Company to Accelerate ObjectivesFebruary 15, 2022 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global, Inc.'s CEO to attend BIO Conference in New YorkFebruary 15, 2022 | finance.yahoo.comNovAccess Global, Inc.'s CEO to attend BIO Conference in New YorkJanuary 18, 2022 | finanznachrichten.deInnovest Global, Inc.: Innovest Global Recaps Recent Milestones and Sets Plan for 2022December 10, 2021 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global, Inc. Names Neil Laird, Chief Financial OfficerDecember 8, 2021 | finance.yahoo.comNovAccess Global, Inc. Names Neil Laird, Chief Financial OfficerNovember 20, 2021 | finance.yahoo.comInnovest Global, Inc. to Accelerate Objectives; GPC Capital and New LeadershipSee More Headlines Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Unsupported plastics film & sheet Sub-IndustryN/A SectorOils/Energy Current SymbolOTCMKTS:XSNX CUSIPN/A CIK1039466 Webwww.xsunx.com Phone(440) 644-1027Fax949-266-5823Employees2Year FoundedN/ACompany Calendar Today6/24/2022Next Earnings (Estimated)8/11/2022Fiscal Year End9/30/2022Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-2.51 million Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-3,817.41% Debt Debt-to-Equity RatioN/A Current Ratio0.02 Quick Ratio0.02 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.62) per share Price / Book-0.24Miscellaneous Outstanding Shares18,399,000Free Float18,134,000Market Cap$2.76 million OptionableNot Optionable Beta1.57 NovAccess Global Frequently Asked Questions How has NovAccess Global's stock price performed in 2022? NovAccess Global's stock was trading at $0.3550 at the beginning of 2022. Since then, XSNX stock has decreased by 57.7% and is now trading at $0.1501. View the best growth stocks for 2022 here. When is NovAccess Global's next earnings date? NovAccess Global is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022. View our earnings forecast for NovAccess Global. Who are NovAccess Global's key executives? NovAccess Global's management team includes the following people: Dr. Dwain K. Morris-Irvin M.P.H., MPH, Ph.D., Chief Exec. Officer (Age 54, Pay $233.49k)Mr. Neil J. Laird, Chief Financial Officer (Age 69)Dr. Christopher Wheeler Ph.D., Pres of Stemvax Therapeutics Who are some of NovAccess Global's key competitors? Some companies that are related to NovAccess Global include Fuwei Films (FFHL), NewHydrogen (NEWH), BioSolar (BSRC), Atlantis Plastics (ATPL), Shiner International (UECN) and STR (STRI). View all of XSNX's competitors. What other stocks do shareholders of NovAccess Global own? Based on aggregate information from My MarketBeat watchlists, some companies that other NovAccess Global investors own include Co-Diagnostics (CODX), iBio (IBIO), PharmaCyte Biotech (PMCB), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Kopin (KOPN), Ascent Solar Technologies (ASTI) and BioRestorative Therapies (BRTX). What is NovAccess Global's stock symbol? NovAccess Global trades on the OTCMKTS under the ticker symbol "XSNX." How do I buy shares of NovAccess Global? Shares of XSNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is NovAccess Global's stock price today? One share of XSNX stock can currently be purchased for approximately $0.15. How much money does NovAccess Global make? NovAccess Global (OTCMKTS:XSNX) has a market capitalization of $2.76 million. How many employees does NovAccess Global have? NovAccess Global employs 2 workers across the globe. How can I contact NovAccess Global? NovAccess Global's mailing address is 8834 MAYFIELD RD, CHESTERLAND OH, 44026. The official website for NovAccess Global is www.xsunx.com. The company can be reached via phone at (440) 644-1027, via email at [email protected], or via fax at 949-266-5823. This page (OTCMKTS:XSNX) was last updated on 6/24/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
